News Agency
The Times

Copper-67 SAR-bisPSMA updates

  • Written by PR Newswire
Copper-67 SAR-bisPSMA updates

SYDNEY, Oct. 16, 2024 /PRNewswire/ -- 

HIGHLIGHTS

Cohort 4 - SECuRE Trial

  • The third participant of cohort 4 (multi-dose) of the SECuRE trial1 has now completed the Dose Limiting Toxicity (DLT) period after a second dose of 12GBq of 67Cu-SAR-bisPSMA, following on from the announcement dated 12 September 20242.
  • The patient is a 93-year-old with a...

Read more: Copper-67 SAR-bisPSMA updates

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion